{
  "DOI": "10.1007/s10689-015-9783-2",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-015-9783-2",
  "alternative-id": [
    "9783"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Nikitina",
      "given": "Dina",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Llacuachaqui",
      "given": "Marcia",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sepkovic",
      "given": "Daniel",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bradlow",
      "given": "H. Leon",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Narod",
      "given": "Steven A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kotsopoulos",
      "given": "Joanne",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2015,
        1,
        23
      ]
    ],
    "date-time": "2015-01-23T12:26:01Z",
    "timestamp": 1422015961000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        8,
        19
      ]
    ],
    "date-time": "2019-08-19T21:49:48Z",
    "timestamp": 1566251388000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        12,
        5
      ]
    ],
    "date-time": "2023-12-05T10:59:35Z",
    "timestamp": 1701773975632
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2015,
        1,
        23
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2015,
          6
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2015,
            1,
            23
          ]
        ],
        "date-time": "2015-01-23T00:00:00Z",
        "timestamp": 1421971200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-015-9783-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-015-9783-2/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-015-9783-2",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "281-286",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2015,
        1,
        23
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2015,
        1,
        23
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2015,
        6
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/S0140-6736(94)91578-4",
      "author": "D Ford",
      "doi-asserted-by": "crossref",
      "first-page": "692",
      "issue": "8899",
      "journal-title": "Lancet",
      "key": "9783_CR1",
      "unstructured": "Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE (1994) Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343(8899):692–695",
      "volume": "343",
      "year": "1994"
    },
    {
      "DOI": "10.1086/375033",
      "author": "A Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "1117",
      "issue": "5",
      "journal-title": "Am J Hum Genet",
      "key": "9783_CR2",
      "unstructured": "Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130",
      "volume": "72",
      "year": "2003"
    },
    {
      "DOI": "10.1038/nrclinonc.2010.166",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "702",
      "issue": "12",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "9783_CR3",
      "unstructured": "Narod SA (2010) BRCA mutations in the management of breast cancer: the state of the art. Nat Rev Clin Oncol 7(12):702–707",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2002.09.023",
      "author": "SR Lakhani",
      "doi-asserted-by": "crossref",
      "first-page": "2310",
      "issue": "9",
      "journal-title": "J Clin Oncol",
      "key": "9783_CR4",
      "unstructured": "Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L et al (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20(9):2310–2318",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1093/jnci/91.17.1475",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "1475",
      "issue": "17",
      "journal-title": "J Natl Cancer Inst",
      "key": "9783_CR5",
      "unstructured": "Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L et al (1999) Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 91(17):1475–1479",
      "volume": "91",
      "year": "1999"
    },
    {
      "DOI": "10.1016/S0140-6736(00)03258-X",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "1876",
      "issue": "9245",
      "journal-title": "Lancet",
      "key": "9783_CR6",
      "unstructured": "Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL et al (2000) Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case–control study. Hereditary Breast Cancer Clinical Study Group. Lancet 356(9245):1876–1881",
      "volume": "356",
      "year": "2000"
    },
    {
      "DOI": "10.1007/s10549-013-2823-4",
      "author": "J Kotsopoulos",
      "doi-asserted-by": "crossref",
      "first-page": "579",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9783_CR7",
      "unstructured": "Kotsopoulos J, Lubinski J, Moller P, Lynch HT, Singer CF, Eng C et al (2014) Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers. Breast Cancer Res Treat 143(3):579–586",
      "volume": "143",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S1470-2045(13)70448-0",
      "author": "M Widschwendter",
      "doi-asserted-by": "crossref",
      "first-page": "1226",
      "issue": "12",
      "journal-title": "Lancet Oncol",
      "key": "9783_CR8",
      "unstructured": "Widschwendter M, Rosenthal AN, Philpott S, Rizzuto I, Fraser L, Hayward J et al (2013) The sex hormone system in carriers of BRCA1/2 mutations: a case–control study. Lancet Oncol 14(12):1226–1232",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.2147/IJWH.S7595",
      "author": "N Obi",
      "doi-asserted-by": "crossref",
      "first-page": "37",
      "journal-title": "Int J Womens Health",
      "key": "9783_CR9",
      "unstructured": "Obi N, Vrieling A, Heinz J, Chang-Claude J (2011) Estrogen metabolite ratio: is the 2-hydroxyestrone to 16α-hydroxyestrone ratio predictive for breast cancer? Int J Womens Health 3:37–51",
      "volume": "3",
      "year": "2011"
    },
    {
      "DOI": "10.1093/carcin/bgp139",
      "author": "A Im",
      "doi-asserted-by": "crossref",
      "first-page": "1532",
      "issue": "9",
      "journal-title": "Carcinogenesis",
      "key": "9783_CR10",
      "unstructured": "Im A, Vogel VG, Ahrendt G, Lloyd S, Ragin C, Garte S et al (2009) Urinary estrogen metabolites in women at high risk for breast cancer. Carcinogenesis 30(9):1532–1535",
      "volume": "30",
      "year": "2009"
    },
    {
      "DOI": "10.1016/0022-4731(89)90138-6",
      "author": "H Adlercreutz",
      "doi-asserted-by": "crossref",
      "first-page": "527",
      "issue": "1–6",
      "journal-title": "J Steroid Biochem",
      "key": "9783_CR11",
      "unstructured": "Adlercreutz H, Fotsis T, Hockerstedt K, Hamalainen E, Bannwart C, Bloigu S et al (1989) Diet and urinary estrogen profile in premenopausal omnivorous and vegetarian women and in premenopausal women with breast cancer. J Steroid Biochem 34(1–6):527–530",
      "volume": "34",
      "year": "1989"
    },
    {
      "author": "GC Kabat",
      "first-page": "505",
      "issue": "7",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "9783_CR12",
      "unstructured": "Kabat GC, Chang CJ, Sparano JA, Sepkovie DW, Hu XP, Khalil A et al (1997) Urinary estrogen metabolites and breast cancer: a case–control study. Cancer Epidemiol Biomark Prev 6(7):505–509",
      "volume": "6",
      "year": "1997"
    },
    {
      "DOI": "10.1093/jnci/91.12.1067",
      "author": "G Ursin",
      "doi-asserted-by": "crossref",
      "first-page": "1067",
      "issue": "12",
      "journal-title": "J Natl Cancer Inst",
      "key": "9783_CR13",
      "unstructured": "Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK et al (1999) Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 91(12):1067–1072",
      "volume": "91",
      "year": "1999"
    },
    {
      "DOI": "10.1038/bjc.1998.663",
      "author": "EN Meilahn",
      "doi-asserted-by": "crossref",
      "first-page": "1250",
      "issue": "9",
      "journal-title": "Br J Cancer",
      "key": "9783_CR14",
      "unstructured": "Meilahn EN, De Stavola B, Allen DS, Fentiman I, Bradlow HL, Sepkovic DW et al (1998) Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up. Br J Cancer 78(9):1250–1255",
      "volume": "78",
      "year": "1998"
    },
    {
      "DOI": "10.1097/00001648-200011000-00004",
      "author": "P Muti",
      "doi-asserted-by": "crossref",
      "first-page": "635",
      "issue": "6",
      "journal-title": "Epidemiology",
      "key": "9783_CR15",
      "unstructured": "Muti P, Bradlow HL, Micheli A, Krogh V, Freudenheim JL, Schunemann HJ et al (2000) Estrogen metabolism and risk of breast cancer: a prospective study of the 2: 16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology 11(6):635–640",
      "volume": "11",
      "year": "2000"
    },
    {
      "author": "GH Ho",
      "first-page": "294",
      "issue": "2",
      "journal-title": "Ann Acad Med Singap",
      "key": "9783_CR16",
      "unstructured": "Ho GH, Luo XW, Ji CY, Foo SC, Ng EH (1998) Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. Ann Acad Med Singap 27(2):294–299",
      "volume": "27",
      "year": "1998"
    },
    {
      "author": "W Zheng",
      "first-page": "505",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "9783_CR17",
      "unstructured": "Zheng W, Dunning L, Jin F, Holtzman J (1998) Correspondence re: G. C. Kabat et al., Urinary estrogen metabolites and breast cancer: a case–control study. Cancer Epidemiol Biomark Prev 6:505–509",
      "volume": "6",
      "year": "1998"
    },
    {
      "author": "W Zheng",
      "first-page": "85",
      "issue": "1",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "9783_CR18",
      "unstructured": "Zheng W, Dunning L, Jin F, Holtzman J (1998) Correspondence re: G. C. Kabat et al., Urinary estrogen metabolites and breast cancer: a case–control study. Cancer Epidemiol Biomark Prev 7(1):85–86",
      "volume": "7",
      "year": "1998"
    },
    {
      "DOI": "10.1016/S0039-128X(02)00116-2",
      "author": "JH Fowke",
      "doi-asserted-by": "crossref",
      "first-page": "65",
      "issue": "1",
      "journal-title": "Steroids",
      "key": "9783_CR19",
      "unstructured": "Fowke JH, Qi D, Bradlow HL, Shu XO, Gao YT, Cheng JR et al (2003) Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection. Steroids 68(1):65–72",
      "volume": "68",
      "year": "2003"
    },
    {
      "DOI": "10.1097/01.ede.0000190543.40801.75",
      "author": "GC Kabat",
      "doi-asserted-by": "crossref",
      "first-page": "80",
      "issue": "1",
      "journal-title": "Epidemiology",
      "key": "9783_CR20",
      "unstructured": "Kabat GC, O’Leary ES, Gammon MD, Sepkovic DW, Teitelbaum SL, Britton JA et al (2006) Estrogen metabolism and breast cancer. Epidemiology 17(1):80–88",
      "volume": "17",
      "year": "2006"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-04-0934",
      "author": "A Wellejus",
      "doi-asserted-by": "crossref",
      "first-page": "2137",
      "issue": "9",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "9783_CR21",
      "unstructured": "Wellejus A, Olsen A, Tjonneland A, Thomsen BL, Overvad K, Loft S (2005) Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study. Cancer Epidemiol Biomark Prev 14(9):2137–2142",
      "volume": "14",
      "year": "2005"
    },
    {
      "DOI": "10.1097/01.ede.0000091607.77374.74",
      "author": "JA Cauley",
      "doi-asserted-by": "crossref",
      "first-page": "740",
      "issue": "6",
      "journal-title": "Epidemiology",
      "key": "9783_CR22",
      "unstructured": "Cauley JA, Zmuda JM, Danielson ME, Ljung BM, Bauer DC, Cummings SR et al (2003) Estrogen metabolites and the risk of breast cancer in older women. Epidemiology 14(6):740–744",
      "volume": "14",
      "year": "2003"
    },
    {
      "DOI": "10.1038/oby.2006.191",
      "author": "A McTiernan",
      "doi-asserted-by": "crossref",
      "first-page": "1662",
      "issue": "9",
      "journal-title": "Obesity",
      "key": "9783_CR23",
      "unstructured": "McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar-Rahmani Y, Modugno F et al (2006) Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity 14(9):1662–1677",
      "volume": "14",
      "year": "2006"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-08-0262",
      "author": "AH Eliassen",
      "doi-asserted-by": "crossref",
      "first-page": "2029",
      "issue": "8",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "9783_CR24",
      "unstructured": "Eliassen AH, Missmer SA, Tworoger SS, Hankinson SE (2008) Circulating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women. Cancer Epidemiol Biomark Prev 17(8):2029–2035",
      "volume": "17",
      "year": "2008"
    },
    {
      "DOI": "10.1023/A:1014896417653",
      "author": "G Ursin",
      "doi-asserted-by": "crossref",
      "first-page": "139",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9783_CR25",
      "unstructured": "Ursin G, London S, Yang D, Tseng CC, Pike MC, Bernstein L et al (2002) Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women. Breast Cancer Res Treat 72(2):139–143",
      "volume": "72",
      "year": "2002"
    },
    {
      "DOI": "10.2147/IJWH.S7595",
      "author": "N Obi",
      "doi-asserted-by": "crossref",
      "first-page": "37",
      "journal-title": "Int J Womens Health",
      "key": "9783_CR26",
      "unstructured": "Obi N, Vrieling A, Heinz J, Chang-Claude J (2011) Estrogen metabolite ratio: is the 2-hydroxyestrone to 16alpha-hydroxyestrone ratio predictive for breast cancer? Int J Womens Health 3:37–51",
      "volume": "3",
      "year": "2011"
    },
    {
      "DOI": "10.1207/s15327914nc5002_5",
      "author": "KM Dalessandri",
      "doi-asserted-by": "crossref",
      "first-page": "161",
      "issue": "2",
      "journal-title": "Nutr Cancer",
      "key": "9783_CR27",
      "unstructured": "Dalessandri KM, Firestone GL, Fitch MD, Bradlow HL, Bjeldanes LF (2004) Pilot study: effect of 3,3′-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutr Cancer 50(2):161–167",
      "volume": "50",
      "year": "2004"
    },
    {
      "DOI": "10.1177/0884533612456043",
      "author": "PE Miller",
      "doi-asserted-by": "crossref",
      "first-page": "599",
      "issue": "5",
      "journal-title": "Nutr Clin Pract",
      "key": "9783_CR28",
      "unstructured": "Miller PE, Snyder DC (2012) Phytochemicals and cancer risk: a review of the epidemiological evidence. Nutr Clin Pract 27(5):599–612",
      "volume": "27",
      "year": "2012"
    },
    {
      "DOI": "10.1038/sj.bjc.6602935",
      "author": "S Fan",
      "doi-asserted-by": "crossref",
      "first-page": "407",
      "issue": "3",
      "journal-title": "Br J Cancer",
      "key": "9783_CR29",
      "unstructured": "Fan S, Meng Q, Auborn K, Carter T, Rosen EM (2006) BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer 94(3):407–426",
      "volume": "94",
      "year": "2006"
    },
    {
      "DOI": "10.1002/ijc.21296",
      "author": "A Nkondjock",
      "doi-asserted-by": "crossref",
      "first-page": "103",
      "issue": "1",
      "journal-title": "Int J Cancer",
      "key": "9783_CR30",
      "unstructured": "Nkondjock A, Ghadirian P, Kotsopoulos J, Lubinski J, Lynch H, Kim-Sing C et al (2006) Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Int J Cancer 118(1):103–107",
      "volume": "118",
      "year": "2006"
    },
    {
      "DOI": "10.1038/bjc.2014.391",
      "author": "J Kotsopoulos",
      "doi-asserted-by": "crossref",
      "first-page": "1269",
      "issue": "7",
      "journal-title": "Br J Cancer",
      "key": "9783_CR31",
      "unstructured": "Kotsopoulos J, Zhang S, Akbari M, Salmena L, Llacuachaqui M, Zeligs M et al (2014) BRCA1 mRNA levels following a 4-6-week intervention with oral 3,3′-diindolylmethane. Br J Cancer 111(7):1269–1274",
      "volume": "111",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S0039-128X(98)00041-5",
      "author": "HL Bradlow",
      "doi-asserted-by": "crossref",
      "first-page": "406",
      "issue": "7–8",
      "journal-title": "Steroids",
      "key": "9783_CR32",
      "unstructured": "Bradlow HL, Sepkovic DW, Klug T, Osborne MP (1998) Application of an improved ELISA assay to the analysis of urinary estrogen metabolites. Steroids 63(7–8):406–413",
      "volume": "63",
      "year": "1998"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-08-0520",
      "author": "GA Reed",
      "doi-asserted-by": "crossref",
      "first-page": "2619",
      "issue": "10",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "9783_CR33",
      "unstructured": "Reed GA, Sunega JM, Sullivan DK, Gray JC, Mayo MS, Crowell JA et al (2008) Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3′-diindolylmethane in healthy subjects. Cancer Epidemiol Biomark Prev 17(10):2619–2624",
      "volume": "17",
      "year": "2008"
    },
    {
      "author": "EI Heath",
      "first-page": "402",
      "issue": "4",
      "journal-title": "Am J Transl Res",
      "key": "9783_CR34",
      "unstructured": "Heath EI, Heilbrun LK, Li J, Vaishampayan U, Harper F, Pemberton P et al (2010) A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3′-diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. Am J Transl Res 2(4):402–411",
      "volume": "2",
      "year": "2010"
    },
    {
      "DOI": "10.1089/thy.2010.0245",
      "author": "S Rajoria",
      "doi-asserted-by": "crossref",
      "first-page": "299",
      "issue": "3",
      "journal-title": "Thyroid",
      "key": "9783_CR35",
      "unstructured": "Rajoria S, Suriano R, Parmar PS, Wilson YL, Megwalu U, Moscatello A et al (2011) 3,3′-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study. Thyroid 21(3):299–304",
      "volume": "21",
      "year": "2011"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-08-3309",
      "author": "S Fan",
      "doi-asserted-by": "crossref",
      "first-page": "6083",
      "issue": "15",
      "journal-title": "Cancer Res",
      "key": "9783_CR36",
      "unstructured": "Fan S, Meng Q, Saha T, Sarkar FH, Rosen EM (2009) Low concentrations of diindolylmethane, a metabolite of indole-3-carbinol, protect against oxidative stress in a BRCA1-dependent manner. Cancer Res 69(15):6083–6091",
      "volume": "69",
      "year": "2009"
    },
    {
      "DOI": "10.4149/neo_2010_04_333",
      "author": "LM Berstein",
      "doi-asserted-by": "crossref",
      "first-page": "333",
      "issue": "4",
      "journal-title": "Neoplasma",
      "key": "9783_CR37",
      "unstructured": "Berstein LM, Koskela A, Boyarkina MP, Adlercreutz H (2010) Excretion of estrogens, catecholestrogens and phytoestrogens in carriers of BRCA1 gene mutations: effects of metformin. Neoplasma 57(4):333–338",
      "volume": "57",
      "year": "2010"
    },
    {
      "DOI": "10.1186/1471-2407-9-148",
      "author": "AL Chand",
      "doi-asserted-by": "crossref",
      "first-page": "148",
      "journal-title": "BMC Cancer",
      "key": "9783_CR38",
      "unstructured": "Chand AL, Simpson ER, Clyne CD, kConFab (2009) Aromatase expression is increased in BRCA1 mutation carriers. BMC Cancer 9:148",
      "volume": "9",
      "year": "2009"
    },
    {
      "DOI": "10.1016/S0140-6736(00)03258-X",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "1876",
      "issue": "9245",
      "journal-title": "Lancet",
      "key": "9783_CR39",
      "unstructured": "Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL et al (2000) Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case–control study. Hereditary Breast Cancer Clinical Study Group. Lancet 356(9245):1876–1881",
      "volume": "356",
      "year": "2000"
    },
    {
      "DOI": "10.1038/sj.onc.1209870",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "5832",
      "issue": "43",
      "journal-title": "Oncogene",
      "key": "9783_CR40",
      "unstructured": "Narod SA (2006) Modifiers of risk of hereditary breast cancer. Oncogene 25(43):5832–5836",
      "volume": "25",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nrc726",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "113",
      "issue": "2",
      "journal-title": "Nat Rev Cancer",
      "key": "9783_CR41",
      "unstructured": "Narod SA (2002) Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer 2(2):113–123",
      "volume": "2",
      "year": "2002"
    },
    {
      "author": "MT Landi",
      "first-page": "173",
      "journal-title": "IARC Sci Publ",
      "key": "9783_CR42",
      "unstructured": "Landi MT, Sinha R, Lang NP, Kadlubar FF (1999) Human cytochrome P4501A2. IARC Sci Publ 148:173–195",
      "volume": "148",
      "year": "1999"
    },
    {
      "DOI": "10.1016/j.tox.2010.08.080",
      "author": "AF Abdull Razis",
      "doi-asserted-by": "crossref",
      "first-page": "74",
      "issue": "1–3",
      "journal-title": "Toxicology",
      "key": "9783_CR43",
      "unstructured": "Abdull Razis AF, Bagatta M, De Nicola GR, Iori R, Ioannides C (2010) Intact glucosinolates modulate hepatic cytochrome P450 and phase II conjugation activities and may contribute directly to the chemopreventive activity of cruciferous vegetables. Toxicology 277(1–3):74–85",
      "volume": "277",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.freeradbiomed.2010.10.703",
      "author": "Z Huang",
      "doi-asserted-by": "crossref",
      "first-page": "228",
      "issue": "2",
      "journal-title": "Free Radic Biol Med",
      "key": "9783_CR44",
      "unstructured": "Huang Z, Zuo L, Zhang Z, Liu J, Chen J, Dong L et al (2011) 3,3′-Diindolylmethane decreases VCAM-1 expression and alleviates experimental colitis via a BRCA1-dependent antioxidant pathway. Free Radic Biol Med 50(2):228–236",
      "volume": "50",
      "year": "2011"
    },
    {
      "DOI": "10.4161/cc.4.9.1993",
      "author": "BB Aggarwal",
      "doi-asserted-by": "crossref",
      "first-page": "1201",
      "issue": "9",
      "journal-title": "Cell Cycle",
      "key": "9783_CR45",
      "unstructured": "Aggarwal BB, Ichikawa H (2005) Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 4(9):1201–1215",
      "volume": "4",
      "year": "2005"
    },
    {
      "DOI": "10.1186/1479-5876-11-252",
      "author": "AJ Bazzan",
      "doi-asserted-by": "crossref",
      "first-page": "252",
      "journal-title": "J Transl Med",
      "key": "9783_CR46",
      "unstructured": "Bazzan AJ, Zabrecky GP, Newberg AB (2013) Multi-nutrient supplement improves hormone ratio associated with cancer risk. J Transl Med 11:252",
      "volume": "11",
      "year": "2013"
    },
    {
      "DOI": "10.1021/tx970217f",
      "author": "H Yamazaki",
      "doi-asserted-by": "crossref",
      "first-page": "659",
      "issue": "6",
      "journal-title": "Chem Res Toxicol",
      "key": "9783_CR47",
      "unstructured": "Yamazaki H, Shaw PM, Guengerich FP, Shimada T (1998) Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem Res Toxicol 11(6):659–665",
      "volume": "11",
      "year": "1998"
    }
  ],
  "reference-count": 47,
  "references-count": 47,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-015-9783-2"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "The effect of oral 3,3′-diindolylmethane supplementation on the 2:16α-OHE ratio in BRCA1 mutation carriers"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "14"
}